Press Coverage
Sofinnova Telethon
Sofinnova Partners charging ahead in Italy
Related Deal lead
Graziano SeghezziRelated Strategy
TelethonCorriere Della Sera, the leading Italian daily, published an article Nov. 22 detailing how Sofinnova Partners is "charging ahead" in Italy, investing €46 million in the country over 2 years and picking up an increasing number of local investors for Sofinnova Partners' Italian projects, the Sofinnova Telethon Strategy and the BiovelocIta accelerator.
"All the work we have done in Italy since 2015 has borne fruit," Graziano Seghezzi, managing partner at Sofinnova Partners, is quoted as saying. "We closed more than half of the 15 investments announced. We tripled the number of Italian investors in our fund, now they are 17 between institutional investors and family offices.”
Seghezzi pointed out that Sofinnova’s Milan offices house the “largest team in Italy dedicated to biotechnology” and that the company assessed 500 investments in Italy over the past three years.
Read the original article, written by Alessandra Puato and published in the weekly insert L'Economia (In Italian).
Related News
T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics towards the clinic
AAVantgarde closes $141 million Series B financing
Mission Therapeutics raises $13.3 million to progress first-in-class Parkinson’s disease candidate MTX325 through clinical trials
NanoPhoria Bioscience secures €83.5 Million Series A to advance breakthrough heart failure therapy and expand portfolio for novel Nano-in-Micro delivery platform
AAVantgarde announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the treatment of Stargardt disease